Hanjoong jo
WebFeb 1, 2010 · Hanjoong Jo. Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia. Search for more papers by this ... Elhammali A, Balachandran K, Jo H, Yoganathan AP. Design of an ex vivo culture system to investigate the effects of shear stress on cardiovascular tissue. J Biomech Eng 130: ... WebCardiovascular Mechanobiology and Nanomedicine Lab; Role of blood flow in Atherosclerosis, and Aortic valve disease; Mechanosensitive genes, MicroRNAs, and …
Hanjoong jo
Did you know?
WebJul 15, 2024 · Disturbed flow (d-flow) induces atherosclerosis by regulating gene expression in endothelial cells (ECs). For further mechanistic understanding, we carried out a single-cell RNA sequencing (scRNAseq) and scATACseq study using endothelial-enriched single-cells from the left- and right carotid artery exposed to d-flow (LCA) and stable-flow ( s-flow in … WebHanjoong Jo, PhD. Associate Chair of Emory Affairs Professor Biomedical Engineering Georgia Institute of Technology. Professor Biomedical Engineering Emory University …
WebJul 28, 2024 · Hanjoong Jo; and ; Yu Huang; Jiang-Yun Luo. Jiang-Yun Luo. Correspondence to: Jiang-Yun Luo, PhD, Institute for Cardiovascular Development and Regenerative Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Bldg 3, Linqing Rd 450, Yangpu District, Shanghai, China. WebThe field of heart valve biomechanics is a rapidly expanding, highly clinically relevant area of research. While most valvular pathologies are rooted in biomechanical changes, the technologies for studying these pathologies and identifying treatments have largely been limited. Nonetheless, significant advancements are underway to better understand the …
WebMar 1, 2024 · Hanjoong Jo: Supervision, Project administration, Writing. Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered aspotential competing interests:HJ is the Founder of FloKines Therapeutics. http://shared.web.emory.edu/emory/news/releases/2010/06/to-predict-atherosclerosis-follow-the-disturbed-blood-flow.html
WebHanjoong Jo’s Post Hanjoong Jo Coulter Distinguished Chair Professor of Biomedical Engineering and Professor of Medicine at Emory and Georgia Tech 2mo ...
WebJul 2, 2024 · Nicolas Villa-Roel, Kitae Ryu & Hanjoong Jo. Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA, USA. Hanjoong Jo. Authors. Nicolas Villa-Roel. View author publications. You can also search for … clcc nursing homeWebFeb 25, 2024 · Hanjoong Jo is John and Jan Portman Professor and Associate Chair in the Coulter Department of Biomedical Engineering (BME) at Emory University ... Dr. Jo has published 180 peer-reviewed papers and edited two books. He is an elected fellow of the Biomedical Engineering Society, American Institute of Medical and Biological ... clc common lawWebHanjoong Jo, Wallace H. Coulter Distinguished Faculty Chair in Biomedical Engineering and the Coulter Department of Biomedical Engineering’s associate chair for Emory University. Carlos A. R. Sa de Melo, professor in the School of Physics, College of Sciences. clc coachesWebView Hanjoong Jo’s profile on LinkedIn, the world’s largest professional community. Hanjoong has 2 jobs listed on their profile. See the complete profile on LinkedIn and ... clc college nightWebJun 23, 2010 · The model is the first to definitively show that disturbances in the patterns of blood flow in an artery determine where atherosclerosis will later appear, says senior author Hanjoong Jo, PhD, Ada Lee and Pete … downsview secondary plan updateWebHanjoong Jo. Professor of Medicine, Wallace H. Coulter Distinguished Faculty Chair in Biomedical Engineering, Associate Chair for Emory. Email. Emory HSRB E170. … downsview secondary planWebJan 14, 2024 · Endothelial cells (ECs) are an important target for therapy in a wide range of diseases, most notably atherosclerosis. Developing efficient nanoparticle (NP) systems that deliver RNA interference (RNAi) drugs specifically to dysfunctional ECs in vivo to modulate their gene expression remains a challenge. downsview sda church .org live stream oct 30